Free Trial

Theralase Technologies (TLT) Insider Trading & Ownership

Theralase Technologies logo
C$0.26
0.00 (0.00%)
(As of 11/4/2024 05:20 PM ET)

Theralase Technologies (CVE:TLT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
8.70%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
C$176.49
Number Of
Insiders Selling
(Last 12 Months)
0
Get TLT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Theralase Technologies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

TLT Insider Buying and Selling by Quarter

Theralase Technologies Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/4/2024Matthew Thomas PerratonDirectorBuy900C$0.20C$176.49
(Data available from 1/1/2013 forward)

TLT Insider Trading Activity - Frequently Asked Questions

The list of insiders at Theralase Technologies includes Matthew Thomas Perraton, and Roger John Dumoulin-White. Learn more on insiders at TLT.

8.70% of Theralase Technologies stock is owned by insiders. Learn more on TLT's insider holdings.

The following insider purchased TLT shares in the last 24 months: Matthew Thomas Perraton (C$176.49).

Insiders have purchased a total of 900 TLT shares in the last 24 months for a total of C$176.49 bought.

Theralase Technologies Key Executives

  • Mr. Roger John Dumoulin-White B.Sc.
    P.Eng., President, CEO & Director
  • Ms. Kristina Hachey CPA
    CFO & Director
  • Dr. Arkady Mandel DSc.
    M.D., Ph.D., Chief Scientific Officer & Director
  • Mr. David M. Groves B.A
    President of World Trade Division
  • Dr. Terry Ruch DVM
    Equine Medical Consultant


This page (CVE:TLT) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners